b'Analyte SpecificReagentsInvivoscribe Analyte Specific Reagents (ASRs) target B- and T-cell antigen receptor loci, FLT3 ITD and TKD, or chromosome translocations(IGH - BCL2, BCR-ABL1, PML-RARA).The ASRs are available as a single tube containing a volume of 1500 L. To ensure the highest quality and reliability of reagents ASRs are manufactured under cGMP and ISO 13485 standards. The analytical and performance characteristics of the ASRs have not been established.Per the current US FDA regulations, ASRs may only be sold to in vitro diagnostic manufacturers, CLIA accredited high complexity laboratories, VHA regulated clinical laboratories, and laboratories not intending to use ASRs as a part of a diagnostic test.ASRs are not available for sale or use outside of the USA.Analyte Specific FLT3 (FMS-like Tyrosine Kinase 3) TRB (T-Cell Receptor Beta Chain Gene Locus)Reagents DescriptionCatalog # DescriptionCatalog #FLT3 ITD Master Mix - Unlabeled Please contact Invivoscribe TCRB V - J1 + 2 - Unlabeled A-205-0010FLT3 TKD Master Mix - Unlabeled Please contact InvivoscribeTCRB V - J1 + 2 - 6FAM & HEX A-205-0011FLT3 ITD Master Mix - 6FAM & HEX - ASR A-412-0071 TCRB V - J2 - Unlabeled A-205-0020FLT3 TKD Master Mix - 6FAM - ASR A-412-0081 TCRB V - J2 - 6FAM A-205-0021TCRB D - J1 + 2 - 6FAM & HEX A-205-0031IGH (Immunoglobulin Heavy Chain Gene Locus)DescriptionCatalog # TRG (T-Cell Receptor Gamma Chain Gene Locus)IGH Framework 1 - 6FAM A-101-0061 DescriptionCatalog #IGH Framework 2 - Unlabeled A-101-0070 TCRG V(2-5,8-11)J 1 + 2+P - 6FAM A-207-0091IGH Framework 2 - 6FAM A-101-0091 TCRG V(1-8,9)J - 6FAM A-207-0071IGH Framework 3 - Unlabeled A-101-0080 TCRG V(1-8)J - HEX A-207-0021IGH Framework 3 - HEX A-101-0081IGH FR1 - 6FAM A-101-0011 IGH-BCL2 t(14;18)IGH FR2 - Unlabeled A-101-0020IGH FR2 - 6FAM A-101-0101 DescriptionCatalog #IGH FR3 - Unlabeled A-101-0030 BCL2/J HMbr - Unlabeled A-309-0050IGH FR3 - HEX A-101-0031 BCL2/J H3Mbr - Unlabeled A-309-0060IGH D H 1 - 6 - HEX A-101-0041 BCL2/J Hmcr - Unlabeled A-309-0070IGH D H 7 - 6FAM A-101-0051IGK (Immunoglobulin Kappa Light Chain Gene Locus)WARRANTY AND LIABILITY DescriptionCatalog #Invivoscribe, Inc. (Invivoscribe) is committed to providing the highest quality products. Invivoscribe warrants that the products meet or exceed the performance standards described in theIGK V - J - Unlabeled A-102-0010Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe. Invivoscribe liability shall not exceed the purchase price of the product. InvivoscribeIGK V - J - 6FAM A-102-0011shall have no liability for direct, indirect, consequential, or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlledIGK V - K de- Unlabeled A-102-0020conditions in purchasers laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative,IGK V - K de- 6FAMA-102-0021and blank controls every time a sample is tested. Ordering, acceptance, and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.NOTICE: The products in this section are Analyte Specific Reagents; the analytical and performance characteristics are not established. Use of many of these products are covered by oneIGL (Immunoglobulin Lambda Light Chain Gene Locus)or more of the following: European Patent Number 1549764, European Patent Number 2418287, European Patent Number 2460889, Japanese Patent Number 4708029, United States Patents 6846630, 8178292, 8859748, 10280462, and related pending and future applications.All of these patents and applications are licensed exclusively to Invivoscribe. Additional patents licensedDescriptionCatalog #to Invivoscribe covering some of these products apply elsewhere. IGL V - J - 6FAM A-103-0011These products require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). No license under these patents to use amplification processes or enzymes is conveyed expressly or by implication to the purchaser by the purchase of these products. Invivoscribe 2021|129'